Patents by Inventor Shixiong Li

Shixiong Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250057834
    Abstract: The present invention relates to a pharmaceutical composition containing alkynyl compound, a preparation method thereof and its application. The present invention discloses a pharmaceutical composition comprising an active pharmaceutical ingredient and an available pharmaceutical excipient; The active pharmaceutical ingredient is 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-benzamide, or its pharmaceutical acceptable salt; The available pharmaceutical excipients includes diluents and lubricants. The pharmaceutical composition can effectively improve the bioavailability of the alkynyl compound, has good dissolution and stability, and improve the drug safety.
    Type: Application
    Filed: August 23, 2024
    Publication date: February 20, 2025
    Inventors: Yanqiong LIN, Jianfeng WEN, Feng XU, Jiaan HUANG, Shixiong LI, Xiaoling HE, Shihe LIANG
  • Patent number: 12097195
    Abstract: The present invention relates to a pharmaceutical composition containing alkynyl compound, a preparation method thereof and its application. The present invention discloses a pharmaceutical composition comprising an active pharmaceutical ingredient and an available pharmaceutical excipient; The active pharmaceutical ingredient is 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-benzamide, or its pharmaceutical acceptable salt; The available pharmaceutical excipients includes diluents and lubricants. The pharmaceutical composition can effectively improve the bioavailability of the alkynyl compound, has good dissolution and stability, and improve the drug safety.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: September 24, 2024
    Assignees: Ascentage Pharma (Suzhou) Co., Ltd., Ascentage Pharma Group Corp Limited, Guangzhou Healthquest Pharma Co., Ltd.
    Inventors: Yanqiong Lin, Jianfeng Wen, Feng Xu, Jiaan Huang, Shixiong Li, Xiaoling He, Shihe Liang
  • Publication number: 20220296587
    Abstract: The present invention relates to a pharmaceutical composition containing alkynyl compound, a preparation method thereof and its application. The present invention discloses a pharmaceutical composition comprising an active pharmaceutical ingredient and an available pharmaceutical excipient; The active pharmaceutical ingredient is 3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-benzamide, or its pharmaceutical acceptable salt; The available pharmaceutical excipients includes diluents and lubricants. The pharmaceutical composition can effectively improve the bioavailability of the alkynyl compound, has good dissolution and stability, and improve the drug safety.
    Type: Application
    Filed: December 9, 2019
    Publication date: September 22, 2022
    Inventors: Yanqiong LIN, Jianfeng WEN, Feng XU, Jiaan HUANG, Shixiong LI, Xiaoling HE, Shihe LIANG
  • Patent number: 10177507
    Abstract: An electrical power coupler is configured to convey electrical power upon detecting that a compatible other coupler is properly aligned and no undesirable operating conditions are detected. The power coupler includes a first ferromagnetic metal adjacent a first magnet, a hall sensor for detecting a magnetic field in the first ferromagnetic metal, and at least two first electrical contacts. A control unit is in electrical communication with the power conductors, and includes an electrical switch operable to selectively allow a flow of electricity from a power source through the associated power conductors when the hall sensor detects the magnetic field, such as when the first electrical contacts are in contact with at least two second electrical contacts of another electrical power coupler. The second electrical contacts make contact with the first electrical contacts upon proper alignment of a correspondingly configured other electrical power coupler.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: January 8, 2019
    Inventors: Norman R. Byrne, Roger D. Burdi, Shixiong Li
  • Publication number: 20170237206
    Abstract: An electrical power coupler is configured to convey electrical power upon detecting that a compatible other coupler is properly aligned and no undesirable operating conditions are detected. The power coupler includes a first ferromagnetic metal adjacent a first magnet, a hall sensor for detecting a magnetic field in the first ferromagnetic metal, and at least two first electrical contacts. A control unit is in electrical communication with the power conductors, and includes an electrical switch operable to selectively allow a flow of electricity from a power source through the associated power conductors when the hall sensor detects the magnetic field, such as when the first electrical contacts are in contact with at least two second electrical contacts of another electrical power coupler. The second electrical contacts make contact with the first electrical contacts upon proper alignment of a correspondingly configured other electrical power coupler.
    Type: Application
    Filed: February 9, 2017
    Publication date: August 17, 2017
    Inventors: Norman R. Byrne, Roger D. Burdi, Shixiong Li, Nickolas J. Morrow